◆英語タイトル:Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C13088
◆発行会社(調査会社):
GlobalData
◆発行日:2019年1月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Sanochemia Pharmazeutika AG (SAC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Sanochemia Pharmazeutika AG (Sanochemia) is a specialty pharmaceutical company that develops and manufactures drugs in selected indication areas such as neurodegeneration, pain and cancer, as well as diagnostic products based on contrast media. The company’s product portfolio includes radiological products including an array of x-ray imaging agents and the MRT imaging agent; and veterinary pharmaceuticals. It also offers synthesis of active pharmaceutical substances (APIs), drug formulation and pharmaceutical production and contract research. Apart from Austria, Sanochemia offers its products in Rest of Europe, Asia, MENA (Middle East and North Africa), Commonwealth of Independent States (CIS) countries and rest of the world. The company has sales offices in Switzerland, Germany, the UK and the US. Sanochemia is headquartered in Vienna, Austria.
Sanochemia Pharmazeutika AG Key Recent Developments
May 24,2018: SANOCHEMIA: Strong EBIT improvement
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Sanochemia Pharmazeutika AG – Key Facts 6
Sanochemia Pharmazeutika AG – Key Employees 7
Sanochemia Pharmazeutika AG – Key Employee Biographies 8
Sanochemia Pharmazeutika AG – Major Products and Services 9
Sanochemia Pharmazeutika AG – History 10
Sanochemia Pharmazeutika AG – Company Statement 12
Sanochemia Pharmazeutika AG – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 15
Company Overview 15
Sanochemia Pharmazeutika AG – Business Description 16
Business Segment: Human Pharmaceutical 16
Overview 16
Performance 16
Business Segment: Production 16
Overview 16
Performance 16
Business Segment: Research and Development (R&D) 16
Overview 16
Performance 17
Business Segment: Veterinary Pharmaceuticals 17
Overview 17
Performance 17
Geographical Segment: Asia 17
Performance 17
Geographical Segment: Austria 17
Performance 17
Geographical Segment: Belgium 17
Performance 17
Geographical Segment: Commonwealth of Independent States 17
Performance 17
Geographical Segment: Germany 17
Performance 17
Geographical Segment: MENA 18
Performance 18
Geographical Segment: Rest of Europe 18
Performance 18
Geographical Segment: Rest of the World 18
Performance 18
Sanochemia Pharmazeutika AG – Corporate Strategy 19
Sanochemia Pharmazeutika AG – SWOT Analysis 20
SWOT Analysis – Overview 20
Sanochemia Pharmazeutika AG – Strengths 20
Sanochemia Pharmazeutika AG – Weaknesses 21
Sanochemia Pharmazeutika AG – Opportunities 22
Sanochemia Pharmazeutika AG – Threats 23
Sanochemia Pharmazeutika AG – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 29
Financial Performance 29
Financial Ratios – Interim Ratios 30
Financial Ratios – Ratio Charts 31
Section 4 – Company’s Lifesciences Financial Deals and Alliances 32
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 32
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 33
Sanochemia Pharmazeutika AG, Recent Deals Summary 34
Section 5 – Company’s Recent Developments 35
May 24, 2018: SANOCHEMIA: Strong EBIT improvement 35
Section 6 – Appendix 36
Methodology 36
Ratio Definitions 36
About GlobalData 40
Contact Us 40
Disclaimer 40
List of Tables
Sanochemia Pharmazeutika AG, Key Facts 6
Sanochemia Pharmazeutika AG, Key Employees 7
Sanochemia Pharmazeutika AG, Key Employee Biographies 8
Sanochemia Pharmazeutika AG, Major Products and Services 9
Sanochemia Pharmazeutika AG, History 10
Sanochemia Pharmazeutika AG, Other Locations 13
Sanochemia Pharmazeutika AG, Subsidiaries 13
Sanochemia Pharmazeutika AG, Key Competitors 24
Sanochemia Pharmazeutika AG, Ratios based on current share price 25
Sanochemia Pharmazeutika AG, Annual Ratios 26
Sanochemia Pharmazeutika AG, Annual Ratios (Cont...1) 27
Sanochemia Pharmazeutika AG, Annual Ratios (Cont...2) 28
Sanochemia Pharmazeutika AG, Interim Ratios 30
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 32
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 33
Sanochemia Pharmazeutika AG, Recent Deals Summary 34
Currency Codes 36
Capital Market Ratios 36
Equity Ratios 37
Profitability Ratios 37
Cost Ratios 38
Liquidity Ratios 38
Leverage Ratios 39
Efficiency Ratios 39
List of Figures
Sanochemia Pharmazeutika AG, Performance Chart (2013 - 2017) 29
Sanochemia Pharmazeutika AG, Ratio Charts 31
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 32
Sanochemia Pharmazeutika AG, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 33